Showing 1 - 13 results of 13 for search 'Jonathan I. Silverberg', query time: 0.02s
Refine Results
-
1
-
2
-
3
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE by Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, Erman Güler
Published 2025-02-01Get full text
Article -
4
The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records Database by Adina R. Lemeshow, Alexander Egeberg, Thomas Edwards, Stephen E. Schachterle, William Romero, Daniela E. Myers, Shefali Vyas, Jonathan I. Silverberg
Published 2025-04-01Get full text
Article -
5
-
6
-
7
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and German... by Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, Jonathan I. Silverberg
Published 2024-12-01Get full text
Article -
8
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry by Jonathan I. Silverberg, Brian M. Calimlim, Ayman Grada, Christopher G. Bunick, Melinda J. Gooderham, Vivian Y. Shi, Chibuzo Obi, Keith D. Knapp, Breda Munoz, Julie M. Crawford, Amy S. Paller
Published 2024-12-01Get full text
Article -
9
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry by Jonathan I. Silverberg, Linda Stein Gold, Seemal Desai, Alexandra Golant, Douglas DiRuggiero, D. Christian Fenske, Alvin Li, Zach Dawson, Yolanda Muñoz Maldonado, Kaylee Ho, Kayla Callahan, Eric L. Simpson
Published 2024-12-01Get full text
Article -
10
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 an... by Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Brad Glick, Petra Staubach, Brian Calimlim, Chao Li, Ayman Grada, Alvaro Moreira, Wan-Ju Lee, Andreas Wollenberg
Published 2025-07-01Get full text
Article -
11
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis by Jonathan I. Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E. Pink, Diego Ruiz Dasilva, Shawn G. Kwatra, Yousef Binamer, Norito Katoh, Valeria Aoki, Alvaro Moreira, Ayman Grada, Chao Li, Brian Calimlim, Wan-Ju Lee, Christopher G. Bunick
Published 2025-06-01Get full text
Article -
12
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Tria... by Eric L. Simpson, Jonathan I. Silverberg, Vimal H. Prajapati, Kilian Eyerich, Norito Katoh, Mark Boguniewicz, Emma Guttman-Yassky, E. James Song, Wan-Ju Lee, Henrique D. Teixeira, Tianshuang Wu, Cristina Sancho Sanchez, Namita Vigna, Brian M. Calimlim, Marjolein de Bruin-Weller
Published 2025-06-01Get full text
Article -
13
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin) by Emma Guttman-Yassky, Stephan Weidinger, Eric L. Simpson, Melinda Gooderham, Alan D. Irvine, Lynda Spelman, Jonathan I. Silverberg, Hany ElMaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Chaoran Hu, Fan Emily Yang, Evangeline Pierce, Laia Bardolet, Diamant Thaçi
Published 2025-06-01Get full text
Article